Sleep drug trial aims to curb cravings in dual addiction
NCT ID NCT05546515
Summary
This study tested whether a prescription sleep medication called Suvorexant could help people who are already receiving treatment for opioid addiction (like methadone) but are also using stimulants like cocaine. Twenty participants were randomly assigned to receive either Suvorexant or a placebo pill for 30 days. Researchers measured if the medication reduced drug use in urine tests, lowered cravings, and improved sleep and stress levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.